Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1993 1
1996 1
1999 1
2002 3
2003 3
2005 1
2006 2
2007 2
2008 4
2009 2
2010 5
2011 4
2012 4
2013 13
2014 11
2015 8
2016 11
2017 8
2018 8
2019 7
2020 2
2021 6
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
In response.
Hubaux R, Thu KL, Lam WL, Alex A. Hubaux R, et al. Among authors: thu kl. J Thorac Oncol. 2013 Nov;8(11):e103-4. doi: 10.1097/01.JTO.0000435739.64803.99. J Thorac Oncol. 2013. PMID: 24128723 Free PMC article. No abstract available.
Polo-like kinase 4 inhibitor CFI-400945 suppresses liver cancer through cell cycle perturbation and eliciting antitumor immunity.
Chan CY, Yuen VW, Chiu DK, Goh CC, Thu KL, Cescon DW, Soria-Bretones I, Law CT, Cheu JW, Lee D, Tse AP, Tan KV, Zhang MS, Wong BP, Wong CM, Khong PL, Ng IO, Bray MR, Mak TW, Yau TC, Wong CC. Chan CY, et al. Among authors: thu kl. Hepatology. 2022 Mar 18. doi: 10.1002/hep.32461. Online ahead of print. Hepatology. 2022. PMID: 35302667
Targeting Mitosis in Cancer: Emerging Strategies.
Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, Mak TW. Dominguez-Brauer C, et al. Among authors: thu kl. Mol Cell. 2015 Nov 19;60(4):524-36. doi: 10.1016/j.molcel.2015.11.006. Mol Cell. 2015. PMID: 26590712 Free article. Review.
CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma.
Chan CY, Chiu DK, Yuen VW, Law CT, Wong BP, Thu KL, Cescon DW, Soria-Bretones I, Cheu JW, Lee D, Tse AP, Zhang MS, Tan KV, Ng IO, Khong PL, Yau TC, Bray MR, Mak TW, Wong CC. Chan CY, et al. Among authors: thu kl. Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2119514119. doi: 10.1073/pnas.2119514119. Epub 2022 Aug 1. Proc Natl Acad Sci U S A. 2022. PMID: 35914158
The detection and implication of genome instability in cancer.
Pikor L, Thu K, Vucic E, Lam W. Pikor L, et al. Among authors: thu k. Cancer Metastasis Rev. 2013 Dec;32(3-4):341-52. doi: 10.1007/s10555-013-9429-5. Cancer Metastasis Rev. 2013. PMID: 23633034 Free PMC article. Review.
Methylation analysis by DNA immunoprecipitation.
Thu KL, Pikor LA, Kennett JY, Alvarez CE, Lam WL. Thu KL, et al. J Cell Physiol. 2010 Mar;222(3):522-31. doi: 10.1002/jcp.22009. J Cell Physiol. 2010. PMID: 20020444 Review.
CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.
Xu H, Di Antonio M, McKinney S, Mathew V, Ho B, O'Neil NJ, Santos ND, Silvester J, Wei V, Garcia J, Kabeer F, Lai D, Soriano P, Banáth J, Chiu DS, Yap D, Le DD, Ye FB, Zhang A, Thu K, Soong J, Lin SC, Tsai AH, Osako T, Algara T, Saunders DN, Wong J, Xian J, Bally MB, Brenton JD, Brown GW, Shah SP, Cescon D, Mak TW, Caldas C, Stirling PC, Hieter P, Balasubramanian S, Aparicio S. Xu H, et al. Among authors: thu k. Nat Commun. 2017 Feb 17;8:14432. doi: 10.1038/ncomms14432. Nat Commun. 2017. PMID: 28211448 Free PMC article.
Methylated DNA immunoprecipitation.
Thu KL, Vucic EA, Kennett JY, Heryet C, Brown CJ, Lam WL, Wilson IM. Thu KL, et al. J Vis Exp. 2009;(23):935. doi: 10.3791/935. J Vis Exp. 2009. PMID: 19241501 Free PMC article.
Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer.
Chari R, Thu KL, Wilson IM, Lockwood WW, Lonergan KM, Coe BP, Malloff CA, Gazdar AF, Lam S, Garnis C, MacAulay CE, Alvarez CE, Lam WL. Chari R, et al. Among authors: thu kl. Cancer Metastasis Rev. 2010 Mar;29(1):73-93. doi: 10.1007/s10555-010-9199-2. Cancer Metastasis Rev. 2010. PMID: 20108112 Free PMC article. Review.
107 results